Canadian Ovarian Cancer Biomarker Project Funded with C$5M | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – Researchers across Canada will use C$5 million (US$4.9 million) in funding from the Terry Fox Research Institute and the Canadian Partnership Against Cancer to create a new validation system for stratifying ovarian cancer patients based on biomarkers and to predict which patients will respond to standard treatments, TFRI said Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.